Indocid (Indometacin)

Indometacin blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for prostaglandin production. By lowering prostaglandin levels, it reduces inflammation, pain, and fever at the site of tissue injury.

The appropriate dose of Indocid is determined by the prescribing healthcare professional based on the specific indication, patient age, weight, renal and hepatic function, and overall clinical response. Patients should follow the prescriber’s instructions exactly.

Safety data for indometacin in pregnancy and lactation are limited. It is generally avoided during the third trimester because of potential fetal risks, and caution is advised while breastfeeding. Clinicians should weigh benefits against possible risks and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the Indocid product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Indocid (indometacin) is a potent NSAID with strong COX inhibition, often considered more effective for certain gout flares and ankylosing spondylitis than some other NSAIDs. However, its gastrointestinal and renal risk profile may be higher, so clinicians balance efficacy against safety when selecting an NSAID for a particular patient.

Store Indocid at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Indocid is supplied as a rectal formulation intended for insertion into the rectum. The exact administration technique should be explained by the healthcare provider, and patients should follow the prescribed schedule and any accompanying instructions for proper use.

The most serious adverse events include gastrointestinal ulceration or bleeding, acute renal failure, severe skin reactions such as Stevens‑Johnson syndrome, and cardiovascular complications. Patients should seek immediate medical attention if they experience signs of bleeding, sudden kidney problems, or severe skin changes.

Indocid is contraindicated in individuals with known hypersensitivity to indometacin or other NSAIDs, active gastrointestinal ulceration or bleeding, severe renal or hepatic impairment, and in the third trimester of pregnancy. Caution is also advised for patients with uncontrolled hypertension, heart failure or a history of cardiovascular disease.